Clinical Trial Update: Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of APOCIII-LRx in healthy volunteers with elevated triglycerides has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• APOCIII-LRx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Elevated Triglycerides (TG) | Phase 1 | Status: COMPLETED